New combo test aims to spot hidden heart risk after attack

NCT ID NCT07268391

Recruiting now Knowledge-focused Sponsor: Instituto de Investigación Biomédica de Salamanca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 4 times

Summary

This study looks at whether combining a new type of CT scan with a blood test for tiny molecules called microRNAs can better predict heart damage after a heart attack. Researchers will follow 95 patients who had a severe heart attack and measure changes in their heart size over six months. The goal is to create a model that identifies high-risk patients early, so they can get closer monitoring and tailored care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a new way to predict which heart attack patients are at risk of heart failure, allowing doctors to monitor them more closely and adjust treatments early.
What could go wrong: This is an early observational study with only 95 participants, so results may not apply to everyone. The new imaging and blood tests may not prove more useful than current methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION (AMI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myocardial infarction myocardial infarction ST-elevation myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE MYOCARDIAL INFARCTION (AMI)

Contacts and locations

Locations

Complejo Asistencial Universitario de Salamanca
RECRUITING

Salamanca, Spain
Hospital Clínico Universitario de Valencia
RECRUITING

Valencia, Spain
Hospital La Princesa
RECRUITING

Madrid, Spain
Hospital Ramón y Cajal
RECRUITING

Madrid, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.